title: Gene therapy for deafness.
abstract: Hearing loss is the most common sensory deficit in humans and can result from genetic, environmental or combined etiologies that prevent normal function of the cochlea, the peripheral sensory organ. Recent advances in understanding the genetic pathways that are critical for the development and maintenance of cochlear function, as well as the molecular mechanisms that underlie cell trauma and death, have provided exciting opportunities for modulating these pathways to correct genetic mutations, to enhance the endogenous protective pathways for hearing preservation and to regenerate lost sensory cells with the possibility of ameliorating hearing loss. A number of recent animal studies have used gene-based therapies in innovative ways toward realizing these goals. With further refinement, some of the protective and regenerative approaches reviewed here may become clinically applicable.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Kresge Hearing Research Institute, The University of Michigan, Ann Arbor, MI, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Kohrman
authors.forename: Y
authors.initials: Y
authors.lastname: Raphael
mesh_terms: D000818:Animals; D003051:Cochlea / Q000503:physiopathology*; D003131:Combined Modality Therapy; D003638:Deafness / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D006310:Hearing Aids; D006801:Humans; D009154:Mutation